CN116496230A - Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone - Google Patents

Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone Download PDF

Info

Publication number
CN116496230A
CN116496230A CN202310479244.1A CN202310479244A CN116496230A CN 116496230 A CN116496230 A CN 116496230A CN 202310479244 A CN202310479244 A CN 202310479244A CN 116496230 A CN116496230 A CN 116496230A
Authority
CN
China
Prior art keywords
dihydro
reaction
benzisothiazolin
benzothiazin
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310479244.1A
Other languages
Chinese (zh)
Inventor
杨科
雒燕琪
李琴
李正义
孙小强
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou University
Original Assignee
Changzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou University filed Critical Changzhou University
Priority to CN202310479244.1A priority Critical patent/CN116496230A/en
Publication of CN116496230A publication Critical patent/CN116496230A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention belongs to the field of fine chemical engineering, and relates to a preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone. Comprising the following steps: adding 1, 2-benzisothiazolin-3-one, selectfluor, ammonium iodide and hydroiodic acid into a sealed tube containing a reaction solvent acetonitrile or 1,4-Dioxane for reaction, and purifying after the reaction is finished to obtain 2, 3-dihydro-4H-1, 3-benzothiazine-4-one. The invention uses cheap and easily available 1, 2-benzisothiazolin-3-one and Selectfluor as raw materials, and ammonium iodide and hydroiodic acid as additives to construct the 2, 3-dihydro-4H-1, 3-benzothiazin-4-one. Wherein SelectFluor can provide a methylene source, and is inserted into a five-membered heterocycle of 1, 2-benzisothiazolin-3-one serving as a raw material to construct 2, 3-dihydro-4H-1, 3-benzothiazin-4-one in one step.

Description

Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone
Technical Field
The invention belongs to the field of fine chemical engineering, and relates to a preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone.
Background
2, 3-dihydro-4H-1, 3-benzothiazin-4-one is an important class of sulfur-nitrogen-containing six-membered heterocyclic compounds, which are widely found in various types of natural products, drugs, foods and materials having pharmaceutical activity.
The literature reports that there are only one example of a method for synthesizing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one: 2-methyl ester thiophenol and paraformaldehyde are used as raw materials, ammonium acetate is used as an additive, and the mixture is refluxed in toluene for 15 hours to obtain 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone with 50 percent yield, and the reaction has the following defects: (1) Using toxic reagent 2-methyl ester thiophenol and paraformaldehyde; (2) the yield is relatively low. Specific synthetic methods are described in (chem. Commun.,2011,47,2137) for support materials.
In previous work, we found that the synthesis of a variety of different 1, 3-benzothiazin-4-one derivatives could be achieved using the fluorinating agent Selectfluor, but this strategy has some limitations: the 1, 3-benzothiazin-4-one derivative with the substituent on N being alkyl can only be synthesized, and when the substituent on N is H or aryl, the reaction can not be carried out (Chinese patent authorization number: ZL201811245251.0; ZL202111461347.2; ZL 202111461346.8).
Disclosure of Invention
The invention aims to provide a novel preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone, which avoids using toxic reagents of 2-methyl ester thiophenol and paraformaldehyde.
The invention relates to a preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone, which comprises the following steps: adding 1, 2-benzisothiazolin-3-one, selectfluor, ammonium iodide and hydroiodic acid into a sealed tube containing a reaction solvent acetonitrile or 1,4-Dioxane for reaction, and purifying after the reaction is finished to obtain 2, 3-dihydro-4H-1, 3-benzothiazine-4-one.
Further, the purification method comprises concentrating the reaction solution and separating by column chromatography.
In order to ensure the efficiency of obtaining the target, the concentration of 1, 2-benzisothiazolin-3-one in the reaction system of the present invention is 0.075 to 0.3mol/L, preferably 0.1mol/L.
To increase the yield, further, NH 4 The molar ratio of the I to the 1, 2-benzisothiazolin-3-one is 1-5:1.
To increase the yield, the molar ratio of HI to 1, 2-benzisothiazolin-3-one is further 1-5:1.
In order to improve the construction efficiency and yield of 2, 3-dihydro-4H-1, 3-benzothiazin-4-one, it is preferable that the reaction solvent is MeCN, and the molar ratio of 1, 2-benzisothiazolin-3-one, selectFluor, ammonium iodide and hydroiodic acid is 1:1:3-5:3-5.
More preferably, the reaction solvent is MeCN,1, 2-benzisothiazolin-3-one, selectfluor, ammonium iodide and hydroiodic acid in a molar ratio of 1.0:1.0:4.0:4.0.
in order to ensure the efficiency of obtaining the target, the reaction temperature is 130-150 ℃, preferably 140 ℃.
In order to ensure the efficiency of the target, the reaction time described in the present invention is 8 to 16 hours, preferably 12 hours.
Compared with the prior art, the invention uses cheap and easily available 1, 2-benzisothiazolin-3-one and Selectfluor as raw materials, and ammonium iodide and hydroiodic acid as additives to construct the 2, 3-dihydro-4H-1, 3-benzothiazine-4-one. Wherein SelectFluor can provide a methylene source, and is inserted into a five-membered heterocycle of 1, 2-benzisothiazolin-3-one serving as a raw material to construct 2, 3-dihydro-4H-1, 3-benzothiazin-4-one in one step.
Detailed Description
The invention is further described in detail below in connection with the examples:
example 1
The synthesis method of the 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone comprises the following steps: acetonitrile (3 mL), 1, 2-benzisothiazolin-3-one (0.3 mmol), selectFluor (0.3 mmol), NH were added sequentially to a 25mL vial 4 I (1.2 mmol) and HI (1.2 mmol), the reaction temperature was controlled at 140℃and the reaction was vigorously stirred for 12 hours. And after the reaction is finished, concentrating the reaction liquid and separating by column chromatography to obtain the 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone with the separation yield of 80 percent.
Nuclear magnetic data and mass spectrum data of target products:
1 H NMR(300MHz,CDCl 3 )δ8.81(br,1H),7.98(d,J=7.6Hz,1H),7.29–7.13(m,3H),4.46(d,J=3.0Hz,2H). 13 C NMR(75MHz,CDCl 3 )δ165.42,136.80,131.06,128.96,127.58,126.38,125.00,41.45.MS(EI)=165.0[M] + .
example 2 (NH) 4 Dosage screening of I
With reference to example 1, only NH was adjusted 4 The dosage of I is as follows: acetonitrile (3 mL), 1, 2-benzisothiazolin-3-one (0.3 mmol), selectFluor (0.3 mmol), NH were added sequentially to a 25mL vial 4 I and HI (1.2 mmol), the reaction temperature was controlled at 140℃and the reaction was stirred vigorously for 12 hours. After the reaction is finished, the reaction liquid is concentrated and separated by column chromatography in sequence, and the specific conditions are as follows:
(1)NH 4 the dosage of I is 0, and the yield of the target product is 29%;
(2)NH 4 the dosage of I is 0.3mmol, and the yield of the target product is 36%;
(3)NH 4 the dosage of I is 0.6mmol, and the yield of the target product is 50%;
(4)NH 4 the dosage of I is 0.9mmol, and the yield of the target product is 65%;
(5)NH 4 the dosage of I is 1.2mmol, and the yield of the target product is 80%;
(6)NH 4 the amount of I used was 1.5mmol, and the yield of the target product was 77%.
Example 3 (quantity screening of HI)
With reference to the method of example 1, only the amount of HI was adjusted, specifically: acetonitrile (2 mL), 1, 2-benzisothiazolin-3-one (0.3 mmol), selectFluor (0.3 mmol), NH were added sequentially to a 25mL vial 4 I (1.2 mmol) and HI, the reaction temperature was controlled at 140℃and the reaction was stirred vigorously for 12 hours. After the reaction is finished, the reaction liquid is concentrated and separated by column chromatography in sequence, and the specific conditions are as follows:
(1) The HI dosage is 0, and the yield of the target product is 0%;
(2) The HI dose is 0.3mmol, and the yield of the target product is 30%;
(3) HI was used in an amount of 0.6mmol and the yield of the target product was 43%;
(4) The HI dose was 0.9mmol and the yield of the target product was 60%;
(5) The HI dose is 1.2mmol, and the yield of the target product is 80%;
(6) HI was used in an amount of 1.5mmol and the yield of the desired product was 70%.
Example 4 (screening of different reaction solvents)
With reference to the method of example 1, only the kind of the solvent is adjusted, and the specific method is as follows: into a 25 mL-sealed tube, various reaction solvents (3 mL), 1, 2-benzisothiazolin-3-one (0.3 mmol), selectFluor (0.3 mmol) and NH were added in this order 4 I (1.2 mmol) and HI (1.2 mmol), the reaction temperature was controlled at 140℃and the reaction was vigorously stirred for 12 hours. After the reaction is finished, the reaction liquid is concentrated and separated by column chromatography in sequence, and the specific conditions are as follows:
(1) The yield of the target product was 80% using MeCN as solvent;
(2) The yield of the target product was 48% using THF as solvent;
(3) The yield of the target product was 19% using DCM as solvent;
(4) The yield of the solvent target product was 54% using 1, 4-Dioxane;
(5) The yield of the solvent target product was 21% using DCE.
(6) In addition, the target product cannot be isolated by using DMF, DMSO, toluene, methanol, and acetone as solvents.
Further, on the basis of the above-mentioned example 1, the concentration of 1, 2-benzisothiazolin-3-one in the reaction system was controlled to be 0.075 to 0.3mol/L; and/or the reaction temperature is 130-150 ℃; and/or when the reaction time is 8-16h, the yield is over 50 percent, and the reaction efficiency is higher. When the concentration of the 1, 2-benzisothiazolin-3-one in the reaction system is 0.075-0.15mol/L; and/or the reaction temperature is 130-150 ℃; and/or when the reaction time is 10-16h, the yield is more than 60%, and when the concentration of the 1, 2-benzisothiazolin-3-one in the reaction system is 0.075-0.1mol/L; and/or the reaction temperature is 140-150 ℃; and/or when the reaction time is 10-14h, the yield is over 70 percent.
The foregoing describes alternative embodiments of the present invention to teach those skilled in the art how to implement and reproduce the invention. Some conventional technical aspects have been simplified and omitted in order to teach the inventive solution. Those skilled in the art will appreciate variations from this aspect that fall within the scope of the invention.

Claims (10)

1. A preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone is characterized in that: the method comprises the following steps: adding 1, 2-benzisothiazolin-3-one, selectfluor, ammonium iodide and hydroiodic acid into a sealed tube containing a reaction solvent acetonitrile or 1,4-Dioxane for reaction, and purifying after the reaction is finished to obtain 2, 3-dihydro-4H-1, 3-benzothiazine-4-one.
2. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the purification method comprises the steps of concentrating and separating the reaction liquid by column chromatography in sequence.
3. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the concentration of the 1, 2-benzisothiazolin-3-one in the reaction system is 0.075-0.3mol/L; and/or the reaction temperature is 130-150 ℃; and/or the reaction time is 8-16h.
4. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the concentration of 1, 2-benzisothiazolin-3-one in the reaction system was 0.1mol/L.
5. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: NH (NH) 4 The molar ratio of the I to the 1, 2-benzisothiazolin-3-one is 1-5:1.
6. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the molar ratio of HI to 1, 2-benzisothiazolin-3-one is 1-5:1.
7. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the reaction solvent is MeCN, and the mole ratio of 1, 2-benzisothiazolin-3-one, selectfluor, ammonium iodide and hydroiodic acid is 1:1:3-5:3-5.
8. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the reaction solvent is MeCN, and the molar ratio of the 1, 2-benzisothiazolin-3-one, the Selectfluor, the ammonium iodide and the hydroiodic acid is 1.0:1.0:4.0:4.0.
9. the method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the reaction temperature was 140 degrees celsius.
10. The method for producing 2, 3-dihydro-4H-1, 3-benzothiazin-4-one according to claim 1, wherein: the reaction time was 12 hours.
CN202310479244.1A 2023-04-28 2023-04-28 Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone Pending CN116496230A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310479244.1A CN116496230A (en) 2023-04-28 2023-04-28 Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310479244.1A CN116496230A (en) 2023-04-28 2023-04-28 Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone

Publications (1)

Publication Number Publication Date
CN116496230A true CN116496230A (en) 2023-07-28

Family

ID=87328083

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310479244.1A Pending CN116496230A (en) 2023-04-28 2023-04-28 Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone

Country Status (1)

Country Link
CN (1) CN116496230A (en)

Similar Documents

Publication Publication Date Title
CN113105468B (en) Polycyclic spiroindolone compound containing benzopyrone and preparation method and application thereof
CN111646964B (en) Novel method for synthesizing 2H-pyran-2-one derivative by base catalysis
CN112920173A (en) Chiral chroman compound and synthesis method thereof
CN112778303A (en) Preparation method of CDK4/6 kinase inhibitor SHR6390
CN116496230A (en) Preparation method of 2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone
CN111995554A (en) Method for preparing asymmetric organic selenium ether compound by metal-free chemical oxidation method
CN115260050B (en) Method for preparing 3-bromo-N-aryl propionamide by using NBS
CN114853648B (en) Method for preparing asymmetric disulfide by NBS (N-bromosuccinimide) to promote breakage of thioether C-S bond
CN110551144A (en) Preparation method of amoxicillin
CN115160220A (en) Synthesis process of pyridine-N-oxide
CN110804012B (en) Method for reducing mercaptal or thioketone for desulfurization
CN110172076B (en) Quinoline derivative containing exocyclic double bond and preparation method thereof
CN108947995B (en) Preparation method of polysubstituted oxadiazine derivative
CN108047179B (en) Fullerene dihydrofuran compound and preparation method thereof
CN116496231A (en) Preparation method of N-phenyl-2, 3-dihydro-4H-1, 3-benzothiazine-4-ketone
CN114478516B (en) 3, 4-dihydro-2H-quinolizin-2-one compound and preparation method thereof
CN115304557B (en) Enamine derivative and preparation method thereof
CN112824387B (en) 2-methyl nicotinate and preparation method and application thereof
CN114181168B (en) Method for preparing N- (substituent) -2-substituent benzothiazine-4-ketone
CN113999152B (en) Synthesis method of cis-1-benzyl-2, 4-dialkoxycarbonyl azetidine
CN114507180B (en) Methyl-substituted azaheterocyclic compound C (sp 3 ) Method for self dehydroalkenylation of H bonds
CN113135865B (en) Method for preparing N-phenyl-3- (benzotriazole-1-yl) propionamide
CN114181169B (en) Method for preparing N- (substituent) benzothiazine-4-ketone without participation of metal
CN111333651B (en) SCF-containing3Or SeCF3Heterocyclic compounds of (5) and process for preparing the same
CN108264531B (en) Preparation method of anecortave acetate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination